118
Views
9
CrossRef citations to date
0
Altmetric
Original Research

High-dose oral N-acetylcysteine fails to improve respiratory health status in patients with chronic obstructive pulmonary disease and chronic bronchitis: a randomized, placebo-controlled trial

, , , , , , , , & show all
Pages 799-807 | Published online: 21 Apr 2016

References

  • American Lung Association [webpage on the Internet]Chronic Obstructive Pulmonary Disease (COPD) Fact Sheet Available from: http://www.lungusa.org/lung-disease/copd/resources/facts-figures/COPD-Fact-Sheet.htmlAccessed March 1, 2016
  • CalverleyPMAAndersonJACelliBTORCH InvestigatorsSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
  • TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
  • FletcherCPetoRTinkerCSpeizerFEThe Natural History of Chronic Bronchitis and EmphysemaOxford, EnglandOxford University Press1976
  • KimVCrinerGJChronic bronchitis and chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187322823723204254
  • CotgreaveIANAC: pharmacological considerations and experimental and clinical applicationsAdv Pharmacol1997382052278895810
  • SheffnerALThe reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetyl-L-cysteineAnn N Y Acad Sci196310629831013977050
  • SutherlandERCrapoJDBowlerRPNAC and exacerbations of chronic obstructive pulmonary diseaseJ COPD200634195202
  • SteyCSteurerJBachmannSMediciTCTramèrMRThe effect of oral NAC in chronic bronchitis: a quantitative systematic reviewEur Respir J200016225326210968500
  • DecramerMRutten-van MölkenMDekhuijzenPNREffects of NAC on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trialLancet200536594701552156015866309
  • ZhengJ-PWenF-QBaiC-XPANTHEON Study GroupTwice daily NAC 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trialLancet Respir Med20142318719424621680
  • De RosaSCZaretskyMDDubsJDNAC replenishes glutathione in HIV infectionEur J Clin Invest2000301091592911029607
  • JonesPWQuirkFHBaveystockCMThe St. George’s respiratory questionnaireRespir Med199185suppl B25311759018
  • KimVCrapoJZhaHCOPDGene InvestigatorsComparison between an alternative and the classic definition of chronic bronchitis in COPDGeneAnn Am Thorac Soc201512333233925575351
  • BoesgaardSAldershvileJPoulsenHEPreventive administration of intravenous NAC and development of tolerance to isosorbide dinitrate in patients with angina pectorisCirculation19928511431491728443
  • AuDHBloughDKKirchderferLWeissKBUdrisEMSullivanSDDevelopment of a quantifiable symptom assessment tool for patients with chronic bronchitis: the Chronic Bronchitis Symptoms Assessment ScaleJ COPD200522209216
  • TarlovARWareJEJrGreenfieldSNelsonECPerrinEZubkoffMThe medical outcomes study: an application of methods for monitoring the results of medical careJAMA198926279259302754793
  • CracowskiJLDurandTBessardGIsoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implicationsTrends Pharmacol Sci200223836036612377577
  • JonesDPLiangYMeasuring the poise of thiol/disulfide couples in vivoFree Radic Biol Med200947101329133819715755
  • AholaTFellmanVKjellmerIRaivioKOLapattoRPlasma 8-isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalaciaPediatr Res2004561889315128912
  • JonesPWSt. George’s respiratory questionnaire: MCIDJ COPD2005217579
  • BjerkSMEdgingtonBDRectorTSKunisakiKMSupplemental vitamin D and physical performance in COPD: a pilot randomized trialInt J Chron Obstruct Pulmon Dis201389710423430315
  • SayinVIIbrahimMXLarssonENilssonJALindahlPBergoMOAntioxidants accelerate lung cancer progression in miceSci Transl Med20146221r a15
  • LanKKGWittesJThe B-value: a tool for data monitoringBiometrics19884425795853390511
  • LachinJMA review of methods for futility stopping based on conditional powerStat Med200524182747276416134130
  • LushchakVIGlutathione homeostasis and functions: potential targets for medical interventionsJ Amino Acids2012201226
  • MoriartySEShahJHLynnMOxidation of glutathione and cysteine in human plasma associated with smokingFree Radic Biol Med20033512158215158288
  • RahmanIAdcockIMOxidative stress and redox regulation of lung inflammation in COPDEur Respir J200628121924216816350
  • AtkuriKRMantovaniJJHerzenbergLAHerzenbergLANAC – a safe antidote for cysteine/glutathione deficiencyCurr Opin Pharmacol20077435535917602868
  • BridgemanMMEMarsdenMSelbyCMorrisonDMacNeeWEffect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissueThorax19944976706758066561
  • StipanukMHDominyJEJrLeeJIColosoRMMammalian cysteine metabolism: new insights into regulation of cysteine metabolismJ Nutr20061366 suppl1652S1659S16702335
  • MeyerABuhlRMagnussenHThe effect of oral NAC on lung glutathione levels in idiopathic pulmonary fibrosisEur Respir J1994734314368013597
  • CantinAMNorthSLHubbardRCCrystalRGNormal alveolar epithelial lining fluid contains high levels of glutathioneJ Appl Physiol19876311521573040659
  • WardCThienFSecombeJGollantSWaltersEHBronchoalveolar lavage fluid urea as a measure of pulmonary permeability in healthy smokersEur Respir J200015228529010706493